Shear-wave elastography of invasive breast cancer: correlation between quantitative mean elasticity value and immunohistochemical profile

被引:0
作者
Ji Hyun Youk
Hye Mi Gweon
Eun Ju Son
Jeong-Ah Kim
Joon Jeong
机构
[1] Gangnam Severance Hospital,Department of Radiology
[2] Yonsei University College of Medicine,Department of Surgery
[3] Gangnam Severance Hospital,undefined
[4] Yonsei University College of Medicine,undefined
来源
Breast Cancer Research and Treatment | 2013年 / 138卷
关键词
Breast cancer; Elastography; Shear-wave elastography; Immunohistochemistry;
D O I
暂无
中图分类号
学科分类号
摘要
To compare the mean elasticity value, as measured by shear-wave elastography (SWE), with immunohistochemical profile of invasive breast cancer. This was an institutional review board-approved retrospective study, with a waiver of informed consent. A total of 166 invasive breast cancers in 152 women undergoing preoperative SWE and surgery were included. Quantitative mean elasticity values in kPa were measured for each lesion by using SWE. Medical records were reviewed to determine palpability, invasive size, lymphovascular invasion, histologic grade, and axillary lymph node status. Based on the immunohistochemical profiles, tumor subtypes were categorized as triple-negative (TN), luminal A and B, or human epidermal growth factor receptor 2-enriched cancer. The mean elasticity value was correlated with clinicopathological features using univariate regression models and multivariate linear regression analysis. Palpability (P < 0.0001), larger size (P = 0.013), lymphovascular invasion (P < 0.0001), higher histologic grade (P < 0.0001), and lymph node involvement (P = 0.018) were significantly associated with the mean elasticity value. For the immunohistochemical profiles and tumor subtypes, the estrogen receptor (P = 0.015), progesterone receptor (P = 0.002), Ki-67 (P = 0.009), and the TN (P = 0.009) tumor subtype were correlated with the mean elasticity value. Multivariate logistic regression analysis showed that the following variables were significantly associated with the mean elasticity value: palpable abnormality, histologic grade, and lymphovascular invasion. No immunohistochemical profile of the cancers was independently correlated with the mean elasticity value. For invasive breast cancers, clinicopathological features of poor prognosis showed higher mean elasticity values than those of good prognosis. However, the immunohistochemical profile showed no independent association with the mean elasticity value.
引用
收藏
页码:119 / 126
页数:7
相关论文
共 278 条
  • [1] Weigelt B(2010)Molecular profiling currently offers no more than tumour morphology and basic immunohistochemistry Breast Cancer Res 12 S5-8423
  • [2] Reis-Filho JS(2003)Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 100 8418-636
  • [3] Sorlie T(2011)Triple negative breast cancer: unmet medical needs Breast Cancer Res Treat 125 627-132
  • [4] Tibshirani R(2009)Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? Diagn Mol Pathol 18 125-1176
  • [5] Parker J(2009)Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial J Clin Oncol 27 1168-57
  • [6] Hastie T(2012)Characteristics and outcomes according to molecular subtypes of breast cancer as classified by a panel of four biomarkers using immunohistochemistry Breast 21 50-750
  • [7] Marron JS(2009)Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer J Natl Cancer Inst 101 736-13
  • [8] Nobel A(2009)Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival Clin Med Res 7 4-1538
  • [9] Deng S(2008)Correlation of ultrasound findings with histology, tumor grade, and biological markers in breast cancer Acta Oncol 47 1531-375
  • [10] Johnsen H(2008)Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression Radiology 246 367-2348